2H,3H,4H-pyrido[1,2-a][1,3,5]triazine-2,4-dione, 95.0%, 250mg

5-Iodopyridine-2-carboxylic acid, 95.0%, 5g

4,4,5,5-Tetramethyl-2-(o-tolyl)-1,3,2-dioxaborolane, 95.0%, 100g

2-(2-Methoxyethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 25g

N-(2-methylbenzyl)-1-butanamine hydrochloride, 95.0%, 5g

4-(2-Chloro-thiazol-5-ylmethyl)-piperazine-1-carboxylic acid tert-butyl ester, 250mg

Pazopanib Hydrochloride>95.0%(HPLC)(T)50mg

Ethyl 3,4-Bis(2-methoxyethoxy)benzoate>98.0%(GC)5g

(3Z)-5-bromo-3-[(3-bromo-4,5-dihydroxyphenyl)methylidene]-1H-indol-2-one, 96%, 25mg

2,4,6-Trichloro-5-(4-chlorophenyl)pyrimidine, 98%, 500mg

6-methyl-2,3-dihydropyridazin-3-one hydrobromide, 95.0%, 25g

5-Bromo-1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 98%, 1g

3-[1-(morpholin-4-yl)ethyl]aniline, 98%, 1g